MYMin Yang

Min Yang

*This is an algorithmically generated author record based on publicly available information.

Current Organizations / Institutes

The organizations/institutes from the scholar's latest article


Min Yang has a total of 10 co-authors. Here are the top co-authors by number of shared publications:

  • Hong-Guang Xu

    Spine Research Center of Wannan Medical College; Key Laboratory of Non-coding RNA Transformation Research of Anhui Higher Education Institution; Dept of Spine Surgery, Yijishan hospital of Wannan Medical College, No. 2, Zhe shan Xi Road, 241001, Wuhu, Anhui, China.

    3 shared publications
  • Zhou-Shan Tao

    Department of Trauma orthopedics, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, No. 2, Zhe shan Xi Road, 241001, Wuhu, Anhui, China

    3 shared publications
  • Cai-Liang Shen

    Department of Spinal Surgery, The First Affiliated Hospital of Anhui Medical University, Hefei, PR China

    1 shared publication
  • Han-Li Lu

    Department of Trauma orthopedics, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, No. 2, Zhe shan Xi Road, 241001, Wuhu, Anhui, China

    1 shared publication
  • Neng-Feng Ma

    Department of Trauma orthopedics, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, No. 2, Zhe shan Xi Road, 241001, Wuhu, Anhui, China

    1 shared publication
  • Rou-Tian Zhang

    Department of Trauma orthopedics, The First Affiliated Hospital of Wannan Medical College, Yijishan Hospital, No. 2, Zhe shan Xi Road, 241001, Wuhu, Anhui, China

    1 shared publication

Latest Publications

  • Open Access

    Tauroursodeoxycholic acid combined with selenium accelerates bone regeneration in ovariectomized rats

    by ZhouShan Tao, Min Yang, Cai-Liang Shen

    More recently, increased studies have revealed that antioxidants can cure osteoporosis by inhibiting oxidative stress. Tauroursodeoxycholic acid (TUDCA) and Selenium (Se) have been confirmed to possess potent anti-oxidative effects and accelerate bone regeneration. In addition, very little is currently known about the effects of a combination with Se and TUDCA on bone defects in osteoporotic states. We, therefore, aimed to assess the protective effect of combination with Se and TUDCA on bone regeneration and investigate the effect and underlying mechanisms. When MC3T3-E1 was cultured in the presence of H2H2, Se, TUDCA and Se/TUDCA therapy could increase the matrix mineralization and promote expression of anti-oxidative stress markers in MC3T3-E1, while reducing intracellular reactive oxygen species (ROS) and mitochondrial ROS levels. Meanwhile, silent information regulator type 1 (SIRT1) was upregulated in response to Se, TUDCA and Se/TUDCA exposures in H2H2 treated-MC3T3-E1. In the OVX rat model, Se, TUDCA and Se/TUDCA showed a clear positive effect against impaired bone repair in osteoporosis. The results above demonstrate that Se/TUDCA exhibits superior efficacy in both cellular and animal experiments, as compared to Se and TUDCA. In conclusion, combination with Se and TUDCA stimulates bone regeneration and is a promising candidate for promoting bone repair in osteoporosis. Graphical abstract


  • Rapamycin could increase the effects of melatonin against age-dependent bone loss

    by Zhou-Shan Tao, Han-Li Lu, Neng-Feng Ma, Rou-Tian Zhang, Yang Li, Min Yang, Hong-Guang Xu

    Previous studies have demonstrated the beneficial effect of melatonin (MEL) on bone tissue and bone metabolism. Rapamycin (RAP) promotes osteoblast proliferation and inhibits osteoclast proliferation, and positively affects bone regeneration; however, reports about effects of RAP on bone loss for aged female rats with MEL administration are limited. This study investigated the impact of treatment with RAP on bone loss for aged female rats with MEL administration. Female Sprague-Dawley rats weighing approximately 520 g were randomly divided into 3 groups of 10: group CON, group MEL and group MEL + RAP and received saline, MEL, RAP plus MEL treatment until death at 12 weeks, respectively. The results of maintaining bone mass and bone strength with RAP plus MEL administration were evaluated by histology, microcomputerized tomography (Micro-CT), gene expression analysis and biomechanical testing. Results from this study indicated that MEL + RAP had stronger effects on the prevention and treatment of osteoporosis than MEL administration. Administration of MEL + RAP produced the strongest effects on bone parameters and strength for distal femurs and regulation of OPG/RANKL signalling pathway-related gene expression. These results seemed to indicate that RAP could increase the effects of MEL on age-dependent bone loss. Frühere Studien haben die positive Wirkung von Melatonin (MEL) auf das Knochengewebe und den Knochenstoffwechsel gezeigt. Rapamycin (RAP) fördert die Osteoblastenproliferation, hemmt die Osteoklastenproliferation und wirkt sich positiv auf die Knochenregeneration aus. Berichte über die Auswirkungen von RAP auf den Knochenverlust bei älteren weiblichen Ratten mit MEL-Verabreichung sind jedoch begrenzt. Diese Studie untersuchte die Auswirkungen der RAP-Behandlung auf den Knochenabbau bei älteren weiblichen Ratten mit MEL-Gabe. Weibliche Sprague-Dawley-Ratten mit einem Gewicht von ca. 520 g wurden in 3 Gruppen randomisiert: Gruppe CON, Gruppe MEL und Gruppe MEL + RAP. Sie erhielten eine Behandlung mit entweder Kochsalzlösung, MEL- oder RAP plus MEL bis zum Tod nach 12 Wochen. Die Ergebnisse der Erhaltung der Knochenmasse und Knochenstärke mit der Verabreichung von MEL + RAP wurden durch Histologie, Mikro-Computertomographie (Mikro-CT), Genexpressionsanalyse und biomechanische Tests bewertet. Die Ergebnisse dieser Studie zeigten, dass MEL + RAP stärkere Auswirkungen auf die Prävention und Behandlung von Osteoporose hatte als die Gabe von MEL. Die Verabreichung von MEL + RAP hatte die stärksten Auswirkungen auf die Knochenparameter sowie die Festigkeit des distalen Femurs und die Regulation der OPG/RANKL-Signalweg-bezogenen Genexpression. Diese Ergebnisse schienen darauf hinzudeuten, dass RAP die Auswirkungen von MEL auf den altersbedingten Knochenabbau verstärken könnte.


  • Resveratrol reverses the negative effect of alcohol on hydroxyapatite-coated implant osseointegration in senile female rats

    by Zhou-Shan Tao, Wan-Shu Zhou, Min Yang, Hongguang Xu

    Previous studies have demonstrated the damaging effect of alcohol (ALH) consumption on bone tissue and bone metabolism. Resveratrol (RES) promotes osteoblast proliferation and inhibits osteoclast proliferation and positively affects bone regeneration; however, reports about effects of RES on osseointegration in aged female rats with ALH consumption are limited. This study was designed to investigate the impact of treatment with RES on osseointegration for aged female rats with ALH consumption. This study included 30 female Sprague-Dawley rats (22 months old), weighing approximately 520 g. All animals were randomly divided into 3 groups of 10: a control group (CON) receiving saline, a group receiving ALH and a group receiving ALH + RES until death after 12 weeks. The results of enhanced osseointegration in senile female rats with RES consumption were evaluated by histology, microcomputerized tomography (micro-CT), gene expression analysis and a biomechanical test. The results of this study indicated that ALH + RES showed stronger effects on the improvement of osseointegration in senile female rats with ALH consumption. The ALH + RES produced stronger effects on bone volume per total volume (BV/TV), mean trabecular thickness (Tb.Th), mean trabecular number (Tb.N) and mean trabecular separation (Tb.Sp), connective tissue density (Conn.D) and maximum push-out force for implants, and regulation of osteogenesis and bone resorption-related gene expression. These results seem to indicate that RES intervention reverses the negative effect of alcohol on hydroxyapatite-coated implant osseointegration in senile female rats with ALH consumption. Bereits publizierte Studien belegen den schädlichen Effekt von Alkoholkonsum auf das Knochengewebe und den Knochenstoffwechsel. Resveratrol (RES) fördert die Osteoblastenproliferation und hemmt die Osteoklastenproliferation, zudem hat es positiven Einfluss auf die Knochenregeneration; die Datenlage zu Effekten von RES auf die Osseointegration bei alten weiblichen Ratten mit Alkoholkonsum ist jedoch limitiert. In der vorliegenden Studie sollte der Einfluss einer Behandlung mit RES auf die Osseointegration bei alten weiblichen Ratten mit Alkoholkonsum untersucht werden. Eingeschlossen wurden 30 weibliche Sprague-Dawley-Ratten (22 Monate alt) mit einem Gewicht von ungefähr 520 g. Alle Tiere wurden in drei Gruppen mit je 10 Individuen randomisiert; eine Kontrollgruppe (CON) erhielt Salzlösung, eine zweite Gruppe Alkohol und eine dritte Alkohol + RES bis zum Tod nach 12 Wochen. Die Resultate einer verstärkten Osseointegration bei alten weiblichen Ratten mit RES-Einnahme wurden mittels histologischer Untersuchung, Mikrocomputertomographie (Mikro-CT), Genexpressionsanalyse und eines biomechanischen Tests überprüft. In dieser Studie wurden unter Alkohol + RES stärkere Effekte auf die Verbesserung der Osseointegration bei alten weiblichen Ratten mit Alkoholkonsum beobachtet. Alkohol + RES hatte stärkere Effekte auf Knochenvolumen pro Gesamtvolumen (BV/TV), Trabekeldicke (Tb.Th), Trabekelzahl (Tb.N), Trabekelabstand (Tb.Sp), die mittlere Bindegewebsdichte (Conn.D), die Push-out-Kraft für Implantate sowie die Regulierung der osteogenese- und knochenresorptionsbezogenen Genexpression. Diese Ergebnisse deuten darauf hin, dass eine RES-Intervention die negative Wirkung von Alkohol auf die Osseointegration hydroxylapatitbeschichteter Implantate bei alten weiblichen Ratten mit Alkoholkonsum umkehrt.


  • Local administration with silymarin could increase osseointegration of hydroxyapatite-coated titanium implants in ovariectomized rats

    by Zhou-Shan Tao, Xing-Jing Wu, Min Yang, Hong-Guang Xu

    As hydroxyapatite has good osteoconductive properties, it is used as coating material for the implants in cementless arthroplasty. However, its effect is not sufficient for osteoporotic bone. Silymarin promotes osteoblast proliferation and inhibits osteoclast proliferation, and positively affects bone regeneration. System administration of silymarin increases bone strength and both cancellous and cortical bone mass. The aim of this study was to confirm the effect of the local incorporation silymarin into hydroxyapatite-coated titanium implants in the osteoporotic and normal condition. Twelve-week-old female Sprague-Dawley rats were used for this study. Twelve weeks after bilateral ovariectomy, all animals were randomly divided into three groups: group sham, group ovariectomized and group silymarin, and the rats from ovariectomized and sham received hydroxyapatite implants and animals belong to group silymarin received silymarin-hydroxyapatite implants until death at 12 weeks, respectively. The bilateral femurs of rats were harvested for evaluation. All treatments increased new bone formation around the surface of titanium rods and push-out force other than group ovariectomized. Compared with group ovariectomized, group silymarin showed the strongest effects on new bone formation, biomechanical strength and regulation of osteogenesis and bone resorption-related gene expression, respectively. Additionally, these are significant difference in bone formation, gene expression and push-out force was observed among treatment groups. This finding suggests that local incorporation of silymarin is useful to improve the fixation of hydroxyapatite-coated implants in ovariectomized rats.